Defects in early B-cell development: Comparing the consequences of abnormalities in pre-BCR signaling in the human and the mouse

Immunological Reviews

Volumn 178, Issue , 2000, Pages 75-90

  Conley, Mary Ellen ^a,b   Rohrer, Jurg ^a,b   Rapalus, Lisa ^a,b   Boylin, Elizabeth C ^a,b   Minegishi, Yoshiyuki ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; PROTEIN TYROSINE KINASE;

B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; ENZYME RECONSTITUTION; EXPRESSION VECTOR; GENE MUTATION; GENE THERAPY; HUMAN; MOUSE; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TRANSGENE; X CHROMOSOME LINKED DISORDER;

EID: 0034502381     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2000.17809.x     Document Type: Review

References (142)

1. Composition and function of T-cell receptor and B-cell receptor complexes on precursor lymphocytes
2. Long-term proliferating early pre B cell lines and clones with the potential to develop to surface Ig-positive, mitogen reactive B cells in vitro and in vivo
3. B cell developmental defects in X-linked immunodeficiency
4. - cord blood stem cells into B cell progenitors in vitro
5. Genetic analysis of B cell antigen receptor signaling
6. Cbl suppresses B cell receptor-mediated phospholipase C (PLC)-γ2 activation by regulating B cell linker protein-PLC-γ2 binding
7. Early B-cell development in the mouse: Insights from mutations introduced by gene targeting
8. Clonal selection and learning in the antibody system
9. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene
10. Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus
11. A critical role of lambda 5 protein in B cell development
12. Aberrant B cell development and immune response in mice with a compromised BCR complex
13. Regulation of an early developmental checkpoint in the B cell pathway by Igβ
14. Mutations in Btk in patients with presumed X-linked agammaglobulinemia
15. Mutations of the human BTK gene coding for bruton tyrosine kinase in X-linked agammaglobulinemia
16. Transcriptional regulatory elements within the first intron of Btk
17. Mutation screening of the BTK gene in 56 families with X-linked agammaglobulinemia (XLA): 47 unique mutations without correlation to clinical course
18. Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease
19. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia
20. The gene involved in X-linked agammaglobulinemia is a member of the src family of protein-tyrosine kinases
21. Mutations in the μ heavy chain gene in patients with agammaglobulinemia
22. Mutations in Igα (CD79a) result in a complete block in B cell development
23. Mutations in the human λ5/14.1 gene result in B cell deficiency and agammaglobulinemia
24. An essential role for BLNK in human B cell development
25. Hypogammaglobulinemia and reduced numbers of B cells in children with myelodysplastic syndrome
26. Genetic basis of abnormal B cell development
27. X-linked agammaglobulinemia: An analysis of 96 patients
28. The rate of spontaneous mutation of a human gene
29. X-linked agammaglobulinemia: New approaches to old questions based on the identification of the defective gene
30. Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: Identification of a mutation which affects the same codon as is altered in immunodeficient xid mice
31. Genomic organization and structure of Bruton agammaglobulinemia tyrosine kinase: Localization of mutations associated with varied clinical presentations and course in X chromosome-linked agammaglobulinemia
32. The spectrum of mutations in Btk that cause X-linked agammaglobulinemia
33. Unusual mutations in Btk: An insertion, a duplication, an inversion and four large deletions
34. A point mutation in the SH2 domain of Bruton's tyrosine kinase in atypical X-linked agammagobulinemia
35. Deficient expression of Bruton's tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection
36. Bruton's tyrosine kinase expression and activity in X-linked agammaglobulinaemia (XLA): The use of protein analysis as a diagnostic indicator of XLA
37. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice
38. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes
39. Antibody deficiencies
40. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies) diagnostic criteria for primary immunodeficiencies
41. Disorders of the B-cell system
42. X-linked immune deficiency (xid) of CBA/N mice
43. Impaired expansion of mouse B cell progenitors lacking Btk
44. Defective B cell development and function in Btk-deficient mice
45. Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre-B cell stage
46. Tec kinases: A family with multiple roles in immunity
47. Mutation of the pleckstrin homology domain of Bruton's tyrosine kinase in immunodeficiency impaired inositol 1,3,4,5-tetrakisphosphate binding capacity
48. A comparative analysis of the phosphoinositide binding specificity of pleckstrin homology domains
49. Tec homology (TH) adjacent to the PH domain
50. The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages
51. Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells
52. A role for Bruton's tyrosine kinase (Btk) in platelet activation by collagen
53. Rapid tyrosine phosphorylation and activation of Bruton's tyrosine/Tec kinases in platelets induced by collagen binding or CD32 cross-linking
54. IL-5 receptor-mediated tyrosine phosphoryhtion of SH2/SH3-containing proteins and activation of Bruton's tyrosine and Janus 2 kinases
55. Association and activation of Btk and Tec tyrosine kinases by gp130, a signal transducer of the interleukin-6 family of cytokines
56. Expression and activation of the nonreceptor tyrosine kinase Tec in human B cells
57. Tyrosine phosphorylation and activation of Bruton tyrosine kinase upon FcεRI cross-linking
58. B-cell antigen receptor stimulation activates the human. Bruton's tyrosine kinase, which is deficient in X-linked agammaglobulinemia
59. Bruton tyrosine kinase is tyrosine phosphorylated and activated in pre-B lymphocytes and receptor-ligated B cells
60. 2+ following B-cell receptor activation
61. Neutropenia in X-linked agammaglobulinemia
62. B lymphocyte precursors in human bone marrow: An analysis of normal individuals and patients with antibody-deficiency states
63. Phenotypic features and proliferative activity of B cell progenitors in X-linked agammaglobulinemia
64. B cells in patients with X-linked agammaglobulinemia
65. Mechanisms and evolutionary origins of variable X-chromosome activity in mammals
66. Unbalanced X chromosome mosaicism in B cells of mice with X-linked immunodeficiency
67. Development of B lymphocytes in mice heterozygous for the X-linked immunodefidency (xid) mutation: Xid inhibits development of all splenic and lymph node B cells at a stage subsequent to their initial formation in bone marrow
68. Expression of the gene defect in X-linked agammaglobulinemia
69. Carrier detection in X-linked agammaglobulinemia by analysis of X-chromosome inactivation
70. Correction of X-linked immunodeficient mice by competitive reconstitution with limiting numbers of normal bone marrow cells
71. B cell heterogeneity. II. Transplantation resistance in xid mice which affects the ontogeny of B cell subpopulations
72. Development of btk transgenic mice
73. Btk dosage determines sensitivity to B cell antigen receptor cross-linking
74. Correction of the X-linked immunodeficiency phenotype by transgenic expression of human Bruton tyrosine kinase under the control of the class II major histocompatibility complex Ea locus control region
75. The X-linked immunodeficiency defect in the mouse is corrected by expression of human Bruton's tyrosine kinase from a yeast artificial chromosome transgene
76. Restoration of lymphocyte function in Janus kinase 3-deficient mice by retroviral-mediated gent transfer
77. Lack of mature B cells in nude mice with X-linked immune deficiency
78. Physiology of B cells in mice with X-linked immunodeficiency (xid) III. Disappearance of xid B cells in double bone marrow chimeras
79. B cell deficiency progresses with lineage maturation in nude. X-linked immunodeficient mice B cell deficiency progresses with lineage maturation
80. X-linked severe combined immunodeficiency: Diagnosis in males with sporadic severe combined immunodeficiency and clarification of clinical findings
81. Interleukin-2 receptor γ-chain mutation results in X-linked severe combined immunodeficiency in humans
82. Mutations of Jak-3 gent in patients with autosomal severe combined immune deficiency (SCID)
83. Mutation of Jak3 in a patient with SCID: Essential role of Jak3 in lymphoid development
84. Membrane-bound immunoglobulin (Ig) and in vitro production of Ig by lymphoid cells from patients with primary immunodeficiencies
85. Hypoimmunoglobulinemia with normal T cell function in female siblings
86. Chronic enteroviral meningoencephalitis in agammaglobulinemic patients
87. Females with a disorder phenotypically identical to X-linked agammaglobulinemia
88. The surrogate light chain in B-cell development
89. Surrogate light chain-dependent selection of Ig heavy chain V regions
90. μ-surrogate light chain physicochemical interactions of the human preB cell receptor: Implications for VH repertoire selection and cell signaling at the preB cell stage
91. Antigen receptors on B lymphocytes
92. Antigen and Fc receptor signaling. The awesome power of the immunoreceptor tyrosine-based activation motif (ITAM)
93. A second gene, VpreB in the lambda 5 locus of the mouse, which appears to be selectively expressed in pre-B lymphocytes
94. Pre-B lymphocyte-specific transcriptional control of the mouse VpreB gene
95. Lambda 5, a new light-chain-related locus selectively expressed in pre-B lymphocytes
96. Identification of three new Ig lambda-like genes in man
97. Organization and expression of the lambda-like genes that contribute to the μ-surrogate light chain complex in human pre-B cells
98. Physical location of the human immunoglobulin lambda-like genes, 14.1, 16.1, and 16.2
99. Novel mechanisms control the folding and assembly of κ5/14.1 and VpreB to produce an intact surrogate light chain
100. Gene conversion events contribute to the polymorphic variation of the surrogate light chain gene lambda 5/14.1
101. Surrogate or conventional light chains are required for membrane immunoglobulin Mu to activate the precursor B cell transition
102. A prematurely expressed Ig(kappa) transgene, but not V(kappa)J(kappa) gene segment targeted into the Ig(kappa) locus, can rescue B cell development in lambda5-deficient mice
103. Light-chain gent expression before heavy-chain gent rearrangement in pre-B cells transformed by Epstein-Barr virus
104. Ig-α cytoplasmic truncation renders immature B cells more sensitive to antigen contact
105. A negative regulatory role for Ig-α during B cell development
106. Analysis of expression of the molecules Ig-α and Ig-β in human pro-B leukemic lines
107. Immunoglobulin β signaling regulates locus accessibility for ordered immunoglobulin gene rearrangements
108. BLNK: A central linker protein in B cell activation
109. SLP-65: A new signaling component in B lymphocytes which requires expression of the antigen receptor for phosphorylation
110. BASH, a novel signaling molecule preferentially expressed in B cells of the bursa of Fabricius
111. BLNK required for coupling Syk to PLCγ2 and Rac1-JNK in B cells
112. Requirement for the leukocyte-specific adapter protein SLP-76 for normal T cell development
113. Impaired viability and profound block in thymocyte development in mice lacking the adaptor protein SLP-76
114. SLP-76 expression is restricted to hemopoietic cells of monocyte, granulocyte, and T lymphocyte lineage and is regulated during T cell maturation and activation
115. Identification of two tyrosine phosphoproteins, pp70 and pp68, which interact with phospholipase Cγ, Grb2, and Vav after B cell antigen receptor activation
116. Association of phospholipase Cγ2 Src homology 2 domains with BLNK is critical for B cell antigen receptor signaling
117. Identification of the SH2 domain binding protein of Bruton's tyrosine kinase as BLNK - Functional significance of Btk-SH2 domain in B-cell antigen receptor-coupled calcium signaling
118. Interaction of SLP adaptors with the SH2 domain of Tec family kinases
119. Requirement for B cell linker protein (BLNK) in B cell development
120. Abnormal development and function of B lymphocytes in mice deficient for the signaling adaptor protein SLP-65
121. The B cell-restricted adaptor BASH is required for normal development and antigen receptor-mediated activation of B cells
122. B cell development and activation defects resulting in xid-like immunodeficiency in BLNK/SLP-65-deficient mice
123. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine
124. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice
125. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor γ chain
126. Defective lymphoid development in mice lacking Jak3
127. Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3
128. + severe combined immunodeficiency
129. JAK3 protein tyrosine kinase mediates interleukin-7-induced activation of phosphatidylinositol-3′ kinase
130. Distinct roles of the phosphatidylinositol 3-kinase and STAT5 pathways in IL-7-mediated development of human thymocyte precursors
131. Syk and Bruton's tyrosine kinase are required for B cell antigen receptor-mediated activation of the kinase Akt
132. The B cell antigen receptor activates the Akt (protein kinase B)/glycogen synthase kinase-3 signaling pathway via phosphatidylinositol 3-kinase
133. Ordered rearrangement of immunoglobulin heavy chain variable region segments
134. Feedback inhibition of immunoglobulin gene rearrangement by membrane μ, but not by secreted μ heavy chains
135. Targeted disruption of μ chain membrane exon causes loss of heavy-chain allelic exclusion
136. Activation of V kappa gene rearrangement in pre-B cells follows the expression of membrane-bound immunoglobulin heavy chains
137. The regulated expression of B lineage associated genes during B cell differentiation in bone marrow and fetal liver
138. Down-regulation of RAG1 and RAG2 gene expression in preB cells after functional immunoglobulin heavy chain rearrangement
139. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow
140. Human B-cell development
141. The expression of Vpre-B/lambda 5 surrogate light chain in early bone marrow precursor B cells of normal and B cell-deficient mutant mice
142. B cell development in the mouse from early progenitors to mature B cells